Literature DB >> 3396699

Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities.

S Oehninger1, A A Acosta, M Morshedi, L Veeck, R J Swanson, K Simmons, Z Rosenwaks.   

Abstract

Sperm morphology evaluated by new, strict criteria is a good predictor of outcome in in vitro fertilization (IVF). This study aimed (1) to determine whether the fertilization rate of preovulatory oocytes in patients with abnormal morphology can be improved by increasing insemination concentration at the time of IVF and (2) to evaluate the pregnancy outcome in patients with abnormal sperm morphology. Three groups were studied: (1) normal morphology, (2) good prognosis pattern, and (3) poor prognosis pattern. All other sperm parameters were normal. Group 3 had a lower overall fertilization rate, lower pregnancy rate/cycle, and lower ongoing pregnancy rate/cycle. Groups 2 and 3 showed a higher miscarriage rate, although not significantly different from group 1. By increasing insemination concentration from 2- to 10-fold, the fertilization rate in group 3 increased from 14.5% to 62.6%. However, pregnancy outcome did not improve. We conclude that patients with severe sperm head abnormalities have a lower ability to establish successful pregnancies, even though fertilization may be achieved.

Entities:  

Mesh:

Year:  1988        PMID: 3396699     DOI: 10.1016/s0015-0282(16)60074-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  An evaluation of the efficacy of in vitro fertilization with intracytoplasmic sperm injection for sperm with low hypoosmotic swelling test scores and poor morphology.

Authors:  Matthew Check; Jerome H Check; Donna Summers-Chase; Kimberly Swenson; Wei Yuan
Journal:  J Assist Reprod Genet       Date:  2003-05       Impact factor: 3.412

2.  In vitro fertilization and gamete micromanipulation in the lowland gorilla.

Authors:  S E Lanzendorf; W J Holmgren; N Schaffer; H Hatasaka; A C Wentz; R S Jeyendran
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

3.  Treatment of severe male-factor infertility with high concentrations of motile sperm by microinsemination in embryo cryopreservation straws.

Authors:  D G Hammitt; D L Walker; C H Syrop; T M Miller; M R Bennett
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-04

4.  Impact of fertilization history and semen parameters on ICSI outcome.

Authors:  R Mercan; S Oehninger; S J Muasher; J P Toner; J Mayer; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

5.  Submicroscopic mathematical evaluation of spermatozoa in assisted reproduction. 2. In vitro fertilization. (Notulae seminologicae. 7)

Authors:  P Piomboni; E Strehler; S Capitani; G Collodel; M De Santo; L Gambera; E Moretti; B Baccetti; K Sterzik
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

6.  Gestational exposure to hydroxyprogesterone caproate suppresses reproductive potential in male rats.

Authors:  T Pushpalatha; P Ramachandra Reddy; P Sreenivasula Reddy
Journal:  Naturwissenschaften       Date:  2005-10-25

7.  There is no relationship between concentration, motility and vacuolated cells.

Authors:  S Aktaş; S Ozkan; P L Cisneros
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

8.  Chromomycin A3 staining as a useful tool for evaluation of male fertility.

Authors:  F G Iranpour; M H Nasr-Esfahani; M R Valojerdi; T M al-Taraihi
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

Review 9.  Role of Abnormal Sperm Morphology in Predicting Pregnancy Outcomes.

Authors:  Samuel A Shabtaie; Sabrina A Gerkowicz; Taylor P Kohn; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

10.  Isolated teratozoospermia and in vitro fertilization.

Authors:  H Figueiredo; A Tavares; L Ferrás; A Couceiro; I Chaves
Journal:  J Assist Reprod Genet       Date:  1996-01       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.